Endorsements & Opposition
President Obama stated that the promise of the PMI is "...delivering the right treatments at the right time, every time, to the right person." Understanding the genetic underpinnings of disease on an individual level would allow physicians to prescribe treatments with the best predicted outcomes. Although enhanced funding and support for genomic research is welcomed by many researchers, clinicians, and patients, some have begun to voice concerns.
- Critics have voiced concerns over a number of issues, including the level of funding, feasibility, unrealistic public expectations, and matters of privacy.
- Other critics have commented that physicians are not qualified or properly trained to interpret complex genetic testing and/or communicate the results to their patients.
- Some have speculated that a focus on health disparities and social determinants of health would be more beneficial to public health
Paige Dexter, PhD Candidate, & Aubrey Incorvaia, MPP